News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AEterna Zentaris (AEZS) To Present Poster On New Therapeutic Opportunities In Oncology With Erk Inhibitors At American Association for Cancer Research Meeting In San Diego


4/1/2014 12:44:17 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free 

GenePool newsletter today!

QUÉBEC CITY, April 1, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ) (the "Company") today announced that a poster will be presented on AEZS-134, a highly potent and selective ATP competitive Erk inhibitor, during the American Association for Cancer Research (AACR) Annual Meeting, which will be held April 5-9, 2014 in San Diego, California.

Abstract #3711: "Erk Inhibition as a Therapeutic Option for the Treatment of Raf- and Mek- Inhibitor Resistant Tumors", I. Seipelt, P. Schmidt, H. Märzhäuser, M. Gerlach, K. Jung, T. Schuster and M. Teifel.
Presenter: Irene Seipelt, PhD, Director, Preclinical Development at Aeterna Zentaris
Poster Session: Experimental and Molecular Therapeutics 26
Date & Time: Tuesday, April 8, 2014, 8 am-12 pm (Pacific time)
Venue: Hall A-E, poster section 31,San Diego Convention Center

About AEZS-134

AEZS-134 is an integral part of the Company's kinase research program comprising the investigation of different compounds for single Erk inhibition, single PI3K inhibition and dual Erk/PI3K kinase inhibition. AEZS-134 selectively inhibits the kinase activity of Erk. AEZS-134 was discovered using the Company's proprietary compound library and high throughput screening technology. AEZS-134 is available for partnering.

About Aeterna Zentaris Inc.

Aeterna Zentaris is a specialty biopharmaceutical company engaged in developing novel treatments in oncology and endocrinology. The Company's pipeline encompasses compounds at various stages of development. For more information, visit www.aezsinc.com.

SOURCE Aeterna Zentaris Inc.



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES